Our findings shed light on the molecular mechanism underlying kidney fibrosis in hyperuricemia‐related CKD, highlighting the significance of ITGAM expression, and signaling as potential therapeutic targets for the prevention and delay of CKD progression. The gene discussed is ITGAM; the disease is hyperuricemia.